Effect of rapamycin on aging and age-related diseases—past and future
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of rapamycin on aging and age-related diseases—past and future
Authors
Keywords
-
Journal
GeroScience
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-10
DOI
10.1007/s11357-020-00274-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation
- (2020) Xiang Chen et al. Aging-US
- Bring Back the Rat!
- (2020) Christy S Carter et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- The mTOR pathway is necessary for survival of mice with short telomeres
- (2020) Iole Ferrara-Romeo et al. Nature Communications
- Pathogens MenTORing Macrophages and Dendritic Cells: Manipulation of mTOR and Cellular Metabolism to Promote Immune Escape
- (2020) Lonneke V. Nouwen et al. Cells
- Post-sepsis immunosuppression depends on NKT cell regulation of mTOR/IFN-γ in NK cells
- (2020) Edy Y. Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of Dendritic Cell Immune Function and Metabolism by Cellular Nutrient Sensor Mammalian Target of Rapamycin (mTOR)
- (2019) Julia P. Snyder et al. Frontiers in Immunology
- Rapamycin and Alzheimer’s disease: Time for a clinical trial?
- (2019) Matt Kaeberlein et al. Science Translational Medicine
- Next generation strategies for geroprotection via mTORC1 inhibition
- (2019) Sabrina N Dumas et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Rapamycin and Alzheimer disease: a double-edged sword?
- (2019) Julian M Carosi et al. Autophagy
- Rapamycin rescues age-related changes in muscle-derived stem/progenitor cells from progeroid mice
- (2019) Yohei Kawakami et al. Molecular Therapy-Methods & Clinical Development
- Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg/Th17 in a mouse model
- (2019) Zhenfei Li et al. NEUROSCIENCE LETTERS
- mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging
- (2019) Candice E. Van Skike et al. AGING CELL
- Rapamycin for longevity: opinion article
- (2019) Mikhail V. Blagosklonny Aging-US
- Melatonin and Rapamycin Attenuate Isoflurane-Induced Cognitive Impairment Through Inhibition of Neuroinflammation by Suppressing the mTOR Signaling in the Hippocampus of Aged Mice
- (2019) Hui Yuan et al. Frontiers in Aging Neuroscience
- Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial
- (2019) Christina Lee Chung et al. GeroScience
- Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatment
- (2019) Ellen Quarles et al. AGING CELL
- Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer’s disease and vascular cognitive impairment
- (2018) Candice E. Van Skike et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Leprdb mice
- (2018) Peter C. Reifsnyder et al. Annals of the New York Academy of Sciences
- Long term rapamycin treatment improves mitochondrial DNA quality in aging mice
- (2018) Jason Bielas et al. EXPERIMENTAL GERONTOLOGY
- A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects
- (2018) Ellen Kraig et al. EXPERIMENTAL GERONTOLOGY
- Repeated Systemic Treatment with Rapamycin Affects Behavior and Amygdala Protein Expression in Rats
- (2018) Martin Hadamitzky et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effects of rapamycin on growth hormone receptor knockout mice
- (2018) Yimin Fang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TORC1 inhibition enhances immune function and reduces infections in the elderly
- (2018) Joan B. Mannick et al. Science Translational Medicine
- Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson’s Disease
- (2018) Débora Masini et al. Frontiers in Neurology
- Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets
- (2018) Aubrey M. Sills et al. AMERICAN JOURNAL OF PRIMATOLOGY
- Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in Tsc-1-Suppressed Brain
- (2018) Rebecca L. Cox et al. Frontiers in Molecular Neuroscience
- Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
- (2018) Antonella Tramutola et al. Translational Neurodegeneration
- Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome
- (2017) Stephanie E Siegmund et al. HUMAN MOLECULAR GENETICS
- MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells
- (2017) Russell G. Jones et al. IMMUNITY
- mTOR drives cerebral blood flow and memory deficits in LDLR−/− mice modeling atherosclerosis and vascular cognitive impairment
- (2017) Jordan B Jahrling et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- NIA Interventions Testing Program: Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse Model
- (2017) Nancy L. Nadon et al. EBioMedicine
- A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs
- (2017) Silvan R. Urfer et al. GeroScience
- Why Women Have More Alzheimer's Disease Than Men: Gender and Mitochondrial Toxicity of Amyloid-β Peptide
- (2017) Jose Viña et al. JOURNAL OF ALZHEIMERS DISEASE
- Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer
- (2016) Randy Strong et al. AGING CELL
- Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways
- (2016) Lisa A. Lesniewski et al. AGING CELL
- Rapamycin Protects Sepsis-Induced Cognitive Impairment in Mouse Hippocampus by Enhancing Autophagy
- (2016) Wenyu Liu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease
- (2016) Ai-Ling Lin et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island
- (2016) Sebastian I. Arriola Apelo et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Activation of mTOR signaling leads to orthopedic surgery-induced cognitive decline in mice through β-amyloid accumulation and tau phosphorylation
- (2016) Wenzhen Shen et al. Molecular Medicine Reports
- Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
- (2016) Alessandro Bitto et al. eLife
- Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson’s Disease: Involvement of the PI3K/Akt/GSK3βPathway
- (2016) Wei Zhang et al. Parkinsons Disease
- Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
- (2016) Elena A. Komarova et al. Aging-US
- New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis
- (2016) Maria Comas et al. Aging-US
- Rapamycin extends life span of Rb1+/− mice by inhibiting neuroendocrine tumors
- (2016) Carolina B. Livi et al. Aging-US
- BMAL1-dependent regulation of the mTOR signaling pathway delays aging
- (2016) Rohini V. Khapre et al. Aging-US
- Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice
- (2015) Vincent Hurez et al. AGING CELL
- Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus)
- (2015) Corinna Ross et al. Aging-US
- How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story
- (2015) Arlan Richardson et al. EXPERIMENTAL GERONTOLOGY
- Rapamycin Increases Mortality indb/dbMice, a Mouse Model of Type 2 Diabetes
- (2015) Kavithalakshmi Sataranatarajan et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
- (2015) Nicolás Herranz et al. NATURE CELL BIOLOGY
- MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
- (2015) Remi-Martin Laberge et al. NATURE CELL BIOLOGY
- Acute Sirolimus Overdose: A Multicenter Case Series
- (2015) Alessandro Ceschi et al. PLoS One
- p53 and rapamycin are additive
- (2015) Barbara Christy et al. Oncotarget
- Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice
- (2015) Simon C. Johnson et al. Frontiers in Genetics
- The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy
- (2015) Robert Siman et al. PLoS One
- Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart
- (2014) Dao-Fu Dai et al. AGING CELL
- Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms
- (2014) Emily L. Goldberg et al. AGING CELL
- Acute systemic rapamycin induces neurobehavioral alterations in rats
- (2014) Martin Hadamitzky et al. BEHAVIOURAL BRAIN RESEARCH
- Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin
- (2014) Irina G Popovich et al. CANCER BIOLOGY & THERAPY
- Longevity, aging and rapamycin
- (2014) Dan Ehninger et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Immune Memory–Boosting Dose of Rapamycin Impairs Macrophage Vesicle Acidification and Curtails Glycolysis in Effector CD8 Cells, Impairing Defense against Acute Infections
- (2014) Emily L. Goldberg et al. JOURNAL OF IMMUNOLOGY
- Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease
- (2014) Teng Jiang et al. NEUROPSYCHOPHARMACOLOGY
- Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
- (2014) Wilson C. Fok et al. PLoS One
- mTOR inhibition improves immune function in the elderly
- (2014) J. B. Mannick et al. Science Translational Medicine
- Strategies for the management of adverse events associated with mTOR inhibitors
- (2014) Bruce Kaplan et al. Transplantation Reviews
- Reduced mammalian target of rapamycin activity facilitates mitochondrial retrograde signaling and increases life span in normal human fibroblasts
- (2013) Chad Lerner et al. AGING CELL
- Late-life rapamycin treatment reverses age-related heart dysfunction
- (2013) James M. Flynn et al. AGING CELL
- Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
- (2013) Richard A. Miller et al. AGING CELL
- eRapa Restores a Normal Life Span in a FAP Mouse Model
- (2013) P. Hasty et al. Cancer Prevention Research
- Chronic Rapamycin Restores Brain Vascular Integrity and Function Through NO Synthase Activation and Improves Memory in Symptomatic Mice Modeling Alzheimer’s Disease
- (2013) Ai-Ling Lin et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Rapamycin extends murine lifespan but has limited effects on aging
- (2013) Frauke Neff et al. JOURNAL OF CLINICAL INVESTIGATION
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
- (2013) Tamara Tchkonia et al. JOURNAL OF CLINICAL INVESTIGATION
- A Transgenic Alzheimer Rat with Plaques, Tau Pathology, Behavioral Impairment, Oligomeric A , and Frank Neuronal Loss
- (2013) R. M. Cohen et al. JOURNAL OF NEUROSCIENCE
- Rapamycin Extends Life and Health in C57BL/6 Mice
- (2013) Yiqiang Zhang et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- mTOR is a key modulator of ageing and age-related disease
- (2013) Simon C. Johnson et al. NATURE
- The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus
- (2013) Rachael Keating et al. NATURE IMMUNOLOGY
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- mTOR Inhibition Ameliorates Cognitive and Affective Deficits Caused by Disc1 Knockdown in Adult-Born Dentate Granule Neurons
- (2013) Miou Zhou et al. NEURON
- Rapamycin Reverses Status Epilepticus-Induced Memory Deficits and Dendritic Damage
- (2013) Amy L. Brewster et al. PLoS One
- Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
- (2013) Sefika Ozcelik et al. PLoS One
- Inhibition of IGF-1R Prevents Ionizing Radiation-Induced Primary Endothelial Cell Senescence
- (2013) Ronald Allan M. Panganiban et al. PLoS One
- Smoking exacerbates amyloid pathology in a mouse model of Alzheimer’s disease
- (2013) Ines Moreno-Gonzalez et al. Nature Communications
- Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-Fluorouracil inPIK3CAmutant gastric cancer cells
- (2012) Bhaskar Bhattacharya et al. CANCER BIOLOGY & THERAPY
- Suppression of replicative senescence by rapamycin in rodent embryonic cells
- (2012) Tatyana V. Pospelova et al. CELL CYCLE
- mTOR Inhibition Prevents Epithelial Stem Cell Senescence and Protects from Radiation-Induced Mucositis
- (2012) Ramiro Iglesias-Bartolome et al. Cell Stem Cell
- Randomized Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stents vs. Sirolimus-Eluting Stents for Percutaneous Coronary Intervention in Chronic Total Occlusion
- (2012) Hun-Jun Park et al. CIRCULATION JOURNAL
- Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence
- (2012) Cecilia A. Hinojosa et al. EXPERIMENTAL GERONTOLOGY
- Inhibition of Mammalian Target of Rapamycin Augments Lipopolysaccharide-Induced Lung Injury and Apoptosis
- (2012) J. A. Fielhaber et al. JOURNAL OF IMMUNOLOGY
- SIRT1 is required for the effects of rapamycin on high glucose-inducing mesangial cells senescence
- (2012) Sifang Zhang et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
- (2012) Peter T. Tsai et al. NATURE
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of Tuberous Sclerosis Complex
- (2012) Marco Cambiaghi et al. NEUROPHARMACOLOGY
- Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice
- (2012) J. Halloran et al. NEUROSCIENCE
- Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival
- (2012) F. J. Ramos et al. Science Translational Medicine
- Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling
- (2011) Smita Majumder et al. AGING CELL
- Rapamycin treatment augments motor neuron degeneration in SOD1G93Amouse model of amyotrophic lateral sclerosis
- (2011) Xiaojie Zhang et al. Autophagy
- S6K inhibition renders cardiac protection against myocardial infarction through PDK1 phosphorylation of Akt
- (2011) Ruomin Di et al. BIOCHEMICAL JOURNAL
- Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases
- (2011) Osama Hussein et al. CANCER LETTERS
- Rapamycin Partially Mimics the Anticancer Effects of Calorie Restriction in a Murine Model of Pancreatic Cancer
- (2011) Laura M. Lashinger et al. Cancer Prevention Research
- Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non-small-cell lung cancer cells
- (2011) Toshiaki Ohara et al. CANCER SCIENCE
- Rapamycin decelerates cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Targeting mTOR globally in cancer: Thinking beyond rapamycin
- (2011) Boris Shor et al. CELL CYCLE
- Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells
- (2011) E. Chiong et al. CLINICAL CANCER RESEARCH
- Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity
- (2011) Leticia M Nogueira et al. ENDOCRINE-RELATED CANCER
- Rapamycin impairs UV induction of mutant-p53 overexpressing cell clusters without affecting tumor onset
- (2011) P. Voskamp et al. INTERNATIONAL JOURNAL OF CANCER
- Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome–associated PTPN11 mutation
- (2011) Talita M. Marin et al. JOURNAL OF CLINICAL INVESTIGATION
- Temsirolimus Inhibits Malignant Pleural Mesothelioma Growth In Vitro and In Vivo: Synergism with Chemotherapy
- (2011) Mir Alireza Hoda et al. Journal of Thoracic Oncology
- Ridaforolimus (AP23573; MK-8669), a Potent mTOR Inhibitor, Has Broad Antitumor Activity and Can Be Optimally Administered Using Intermittent Dosing Regimens
- (2011) V. M. Rivera et al. MOLECULAR CANCER THERAPEUTICS
- Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits
- (2011) Smita Majumder et al. PLoS One
- Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin
- (2011) Olga V. Leontieva et al. PLoS One
- Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage
- (2011) Loredana Stoica et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells
- (2011) K. Cao et al. Science Translational Medicine
- Are we ready to move away from nature? The rapamycin story
- (2011) Monica Mita et al. Targeted Oncology
- Common toxicities of mammalian target of rapamycin inhibitors
- (2011) Scott A. Soefje et al. Targeted Oncology
- The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas
- (2011) Sushma Vemulapalli et al. Targeted Oncology
- Mammalian Target of Rapamycin (mTOR) Regulates Cellular Proliferation and Tumor Growth in Urothelial Carcinoma
- (2010) Donna E. Hansel et al. AMERICAN JOURNAL OF PATHOLOGY
- Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
- (2010) Vladimir N. Anisimov et al. AMERICAN JOURNAL OF PATHOLOGY
- Rapamycin Inhibits Anal Carcinogenesis in Two Preclinical Animal Models
- (2010) M. K. Stelzer et al. Cancer Prevention Research
- Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
- (2010) Antonella Caccamo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cutting Edge: Rapamycin Augments Pathogen-Specific but Not Graft-Reactive CD8+ T Cell Responses
- (2010) I. R. Ferrer et al. JOURNAL OF IMMUNOLOGY
- Rapamycin Protects against Neuron Death in In Vitro andIn Vivo Models of Parkinson's Disease
- (2010) C. Malagelada et al. JOURNAL OF NEUROSCIENCE
- Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
- (2010) Richard A. Miller et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- Participation of Mammalian Target of Rapamycin Complex 1 in Toll-Like Receptor 2– and 4–Induced Neutrophil Activation and Acute Lung Injury
- (2009) Emmanuel Lorne et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor
- (2009) L Zhao et al. BRITISH JOURNAL OF PHARMACOLOGY
- mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and Aging
- (2009) Rogerio M. Castilho et al. Cell Stem Cell
- Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer’s disease
- (2009) Ewa Kloskowska et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies
- (2009) Jozef Hanes et al. JOURNAL OF NEUROCHEMISTRY
- Beneficial Effects of Mammalian Target of Rapamycin Inhibition on Left Ventricular Remodeling After Myocardial Infarction
- (2009) Sebastian J. Buss et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Expression and mechanism of mammalian target of rapamycin in age-related renal cell senescence and organ aging
- (2009) Li Zhuo et al. MECHANISMS OF AGEING AND DEVELOPMENT
- mTOR regulates memory CD8 T-cell differentiation
- (2009) Koichi Araki et al. NATURE
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
- (2009) David E. Harrison et al. NATURE
- Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells
- (2009) Chinnaswamy Jagannath et al. NATURE MEDICINE
- Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling
- (2009) Emma Puighermanal et al. NATURE NEUROSCIENCE
- Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APCMin/+ mice
- (2009) G E Koehl et al. ONCOGENE
- mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
- (2009) C. Chen et al. Science Signaling
- The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
- (2008) Thomas Weichhart et al. IMMUNITY
- mTOR: The Mammalian Target of Replication
- (2008) Ezra E.W. Cohen JOURNAL OF CLINICAL ONCOLOGY
- Sirolimus-Induced Vascular Dysfunction
- (2008) Alexander Jabs et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diabetes after Transplantation and Sirolimus: What's the Connection?
- (2008) M. Pavlakis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rapamycin Inhibits Polyglutamine Aggregation Independently of Autophagy by Reducing Protein Synthesis
- (2008) M. A. King et al. MOLECULAR PHARMACOLOGY
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
- Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in Apc 716 mice
- (2008) T. Fujishita et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
- (2008) Jean-Philippe Coppé et al. PLOS BIOLOGY
- Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR−/− mice despite severe hypercholesterolemia
- (2007) Marc A. Mueller et al. ATHEROSCLEROSIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started